VIVEbiotech strengthens its fully integrated model for lentiviral vector manufacturing
The company reinforces its full-integration approach, managing every stage of the process — from development to fill & finish — to ensure the highest standards of quality, consistency, and compliance.
At VIVEbiotech, excellence and reliability are at the core of everything we do. As our Chief Operating Officer, Diego Bochoeyer, explains in a new corporate video, one of our key strengths lies in the complete integration of the lentiviral vector manufacturing process.
This approach allows us to oversee every stage through a fully in-house process — from early development to sterile filling, sealing, labeling, and secondary packaging (fill & finish). By doing so, we maintain full control over quality, timelines, and compliance, ensuring that every batch meets the highest industry standards.
Our mission is simple: consistency, reliability, and excellence, because patients deserve nothing less.
VIVEbiotech continues to advance the manufacturing of lentiviral vectors for advanced therapies, helping bring innovative treatments closer to those who need them most.
🎥 Watch the full video here.